Biotech firms anticipate FDA approval, test results in 2008

12/31/2007 | Washington Post (tiered subscription model), The

Many biotech companies will face "make-or-break moments" related to trial results and product approvals in 2008, industry expert Edward M. Rudnic said. United Therapeutics Corp. and GenVec are expecting clinical trial results of their drug candidates for pulmonary hypertension and pancreatic cancer, respectively, and MiddleBrook Pharmaceuticals and Vanda Pharmaceuticals are expecting FDA decisions on drugs for amoxicillin and schizophrenia.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Chicago, IL
Senior Manager, Compliance
Fremont, CA
Manager, Business Conduct
Foster City, CA
Product Patent Attorney
Foster City, CA
Employment Counsel
Foster City, CA